Content area

Abstract

Human p300 is a transcriptional co-activator and a major acetyltransferase that acetylates histones and other proteins facilitating gene transcription. The activity of p300 relies on the fine-tuned interactome that involves a dozen p300 domains and hundreds of binding partners and links p300 to a wide range of vital signaling events. Here, we report a novel function of the ZZ-type zinc finger (ZZ) of p300 as a reader of histone H3. We show that the ZZ domain and acetyllysine-recognizing bromodomain of p300 play critical roles in modulating p300 enzymatic activity and its association with chromatin. The acetyllysine binding function of bromodomain is essential for acetylation of histones H3 and H4, whereas interaction of the ZZ domain with H3 promotes selective acetylation of the histone H3K27 and H3K18 sites.

Details

Title
The ZZ domain of p300 mediates specificity of the adjacent HAT domain for histone H3
Author
Zhang, Yi 1   VIAFID ORCID Logo  ; Xue, Yongming 2   VIAFID ORCID Logo  ; Shi, Jiejun 3   VIAFID ORCID Logo  ; Ahn, JaeWoo 1 ; Mi, Wenyi 4   VIAFID ORCID Logo  ; Muzaffar, Ali 1 ; Wang, Xiaolu 4 ; Klein, Brianna J 1 ; Wen, Hong 4 ; Li, Wei 3   VIAFID ORCID Logo  ; Shi, Xiaobing 5   VIAFID ORCID Logo  ; Kutateladze, Tatiana G 1   VIAFID ORCID Logo 

 Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO, USA 
 Department of Epigenetics and Molecular Carcinogenesis, Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Genetics and Epigenetics Graduate Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA 
 Dan L. Duncan Cancer Center, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA 
 Department of Epigenetics and Molecular Carcinogenesis, Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Center for Epigenetics, Van Andel Research Institute, Grand Rapids, MI, USA 
 Department of Epigenetics and Molecular Carcinogenesis, Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Genetics and Epigenetics Graduate Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA; Center for Epigenetics, Van Andel Research Institute, Grand Rapids, MI, USA 
Pages
841-849
Publication year
2018
Publication date
Sep 2018
Publisher
Nature Publishing Group
ISSN
15459993
e-ISSN
15459985
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2188973091
Copyright
Copyright Nature Publishing Group Sep 2018